EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 130 filers reported holding EXELIXIS INC in Q3 2014. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,000 | -77.4% | 475 | -80.6% | 0.00% | -100.0% |
| Q3 2016 | $31,000 | -3.1% | 2,450 | -39.5% | 0.00% | 0.0% |
| Q2 2016 | $32,000 | +23.1% | 4,050 | -38.6% | 0.00% | 0.0% |
| Q1 2016 | $26,000 | -29.7% | 6,600 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $37,000 | +146.7% | 6,600 | +135.7% | 0.00% | 0.0% |
| Q3 2015 | $15,000 | +36.4% | 2,800 | 0.0% | 0.00% | – |
| Q2 2015 | $11,000 | +175.0% | 2,800 | +86.7% | 0.00% | – |
| Q1 2015 | $4,000 | +100.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2014 | $2,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q3 2014 | $2,000 | -60.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2014 | $5,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2014 | $5,000 | -44.4% | 1,500 | 0.0% | 0.00% | – |
| Q4 2013 | $9,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |